In the last 12 months, insiders at Xenon Pharmaceuticals Inc. ($XENE) filed 141 transactions with the SEC: 0 open-market purchases totaling $0 and 38 sales totaling $25,986,731. Net insider sentiment: net selling.
Xenon Pharmaceuticals Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- MORTIMER IAN (PRESIDENT & CEO) — 48 transactions totaling $25,604,303
- AULIN SHERRY (Chief Financial Officer) — 9 transactions totaling $1,317,785
- MORTIMER IAN (PRESIDENT, CEO & INTERIM CFO) — 3 transactions totaling $1,196,250
- GANNON STEVEN (Not found) — 10 transactions totaling $666,366
- ROBIN SHERRINGTON (EVP, Strategy & Innovation) — 10 transactions totaling $484,528
View all SEC Filings for Xenon Pharmaceuticals Inc. (XENE).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | S | Common Shares | 1410 | $55.23 | 7,069.0000 | 79,247,976 | 16.63% | 0.00% |
| March 12, 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | M | Restricted Share Units | 3750 | $0.00 | 11,250.0000 | 79,247,976 | 25.00% | 0.00% |
| March 12, 2026 | DiFabio Andrea | Chief Legal Officer | M | Common Shares | 3750 | $0.00 | 8,643.0000 | 79,247,976 | 76.64% | 0.00% |
| March 13, 2026 | DiFabio Andrea | Chief Legal Officer | S | Common Shares | 1342 | $55.23 | 7,301.0000 | 79,247,976 | 15.53% | 0.00% |
| March 12, 2026 | DiFabio Andrea | Chief Legal Officer | M | Restricted Share Units | 3750 | $0.00 | 11,250.0000 | 79,247,976 | 25.00% | 0.00% |
| March 12, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Common Shares | 12500 | $0.00 | 41,531.0000 | 79,247,976 | 43.06% | 0.02% |
| March 13, 2026 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 7308 | $55.23 | 34,223.0000 | 79,247,976 | 17.60% | 0.01% |
| March 12, 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | M | Common Shares | 3750 | $0.00 | 8,479.0000 | 79,247,976 | 79.30% | 0.00% |
| March 12, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Restricted Share Units | 12500 | $0.00 | 37,500.0000 | 79,247,976 | 25.00% | 0.02% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Common Shares | 75000 | $8.40 | 95,300.0000 | 79,247,976 | 369.46% | 0.09% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 31694 | $59.88 | 41,815.0000 | 79,247,976 | 43.12% | 0.04% |
| March 9, 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | M | Common Shares | 7500 | $0.00 | 7,500.0000 | 79,247,976 | 9999.99% | 0.01% |
| March 10, 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | S | Common Shares | 2771 | $60.11 | 4,729.0000 | 79,247,976 | 36.95% | 0.00% |
| March 9, 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | A | Performance Share Units | 7500 | $0.00 | 7,500.0000 | 79,247,976 | 9999.99% | 0.01% |
| March 9, 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | M | Performance Share Units | 7500 | $0.00 | 0.0000 | 79,247,976 | 100.00% | 0.01% |
| March 9, 2026 | DiFabio Andrea | Chief Legal Officer | M | Common Shares | 7500 | $0.00 | 7,500.0000 | 79,247,976 | 9999.99% | 0.01% |
| March 10, 2026 | DiFabio Andrea | Chief Legal Officer | S | Common Shares | 2607 | $60.11 | 4,893.0000 | 79,247,976 | 34.76% | 0.00% |
| March 9, 2026 | DiFabio Andrea | Chief Legal Officer | A | Performance Share Units | 7500 | $0.00 | 7,500.0000 | 79,247,976 | 9999.99% | 0.01% |
| March 9, 2026 | DiFabio Andrea | Chief Legal Officer | M | Performance Share Units | 7500 | $0.00 | 0.0000 | 79,247,976 | 100.00% | 0.01% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 43348 | $59.26 | 86,952.0000 | 79,247,976 | 33.27% | 0.05% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Common Shares | 105000 | $4.75 | 125,300.0000 | 79,247,976 | 517.24% | 0.13% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 2449 | $61.26 | 20,300.0000 | 79,247,976 | 10.77% | 0.00% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 10072 | $60.47 | 22,749.0000 | 79,247,976 | 30.69% | 0.01% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 12479 | $59.50 | 32,821.0000 | 79,247,976 | 27.55% | 0.02% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Common Shares | 25000 | $3.10 | 45,300.0000 | 79,247,976 | 123.15% | 0.03% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 21515 | $60.49 | 20,300.0000 | 79,247,976 | 51.45% | 0.03% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 21791 | $58.81 | 73,509.0000 | 79,247,976 | 22.87% | 0.03% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Performance Share Units | 20000 | $0.00 | 0.0000 | 79,247,976 | 100.00% | 0.03% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | A | Performance Share Units | 20000 | $0.00 | 20,000.0000 | 79,247,976 | 9999.99% | 0.03% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Stock Option | 65000 | $0.00 | 0.0000 | 79,247,976 | 100.00% | 0.08% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Stock Option | 105000 | $0.00 | 0.0000 | 79,247,976 | 100.00% | 0.13% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Stock Option | 25000 | $0.00 | 0.0000 | 79,247,976 | 100.00% | 0.03% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Stock Option | 75000 | $0.00 | 0.0000 | 79,247,976 | 100.00% | 0.09% |
| March 10, 2026 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 11269 | $60.11 | 29,031.0000 | 79,247,976 | 27.96% | 0.01% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Common Shares | 20000 | $0.00 | 40,300.0000 | 79,247,976 | 98.52% | 0.03% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 65000 | $62.06 | 20,300.0000 | 79,247,976 | 76.20% | 0.08% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Common Shares | 65000 | $9.44 | 85,300.0000 | 79,247,976 | 320.20% | 0.08% |
| March 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 61652 | $60.08 | 20,300.0000 | 79,247,976 | 75.23% | 0.08% |
| Jan. 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | A | Restricted Share Units | 65000 | $0.00 | 65,000.0000 | 79,247,976 | 9999.99% | 0.08% |
| Jan. 9, 2026 | MORTIMER IAN | PRESIDENT & CEO | A | Share Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 79,247,976 | 9999.99% | 0.44% |
| Jan. 9, 2026 | DiFabio Andrea | Chief Legal Officer | A | Restricted Share Units | 15000 | $0.00 | 15,000.0000 | 79,247,976 | 9999.99% | 0.02% |
| Jan. 9, 2026 | DiFabio Andrea | Chief Legal Officer | A | Share Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 79,247,976 | 9999.99% | 0.10% |
| Jan. 9, 2026 | Cline Darren S | Chief Commercial Officer | A | Restricted Share Units | 20000 | $0.00 | 20,000.0000 | 79,247,976 | 9999.99% | 0.03% |
| Jan. 9, 2026 | Cline Darren S | Chief Commercial Officer | A | Share Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 79,247,976 | 9999.99% | 0.05% |
| Jan. 9, 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | A | Restricted Share Units | 20000 | $0.00 | 20,000.0000 | 79,247,976 | 9999.99% | 0.03% |
| Jan. 9, 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | A | Share Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 79,247,976 | 9999.99% | 0.13% |
| Jan. 2, 2026 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 2062 | $44.93 | 20,300.0000 | 79,247,976 | 9.22% | 0.00% |
| Jan. 2, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 79,247,976 | 100.00% | 0.05% |
| Jan. 2, 2026 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 37938 | $44.40 | 22,362.0000 | 79,247,976 | 62.92% | 0.05% |
| Jan. 2, 2026 | MORTIMER IAN | PRESIDENT & CEO | M | Common Shares | 40000 | $7.49 | 60,300.0000 | 79,247,976 | 197.04% | 0.05% |
| Dec. 8, 2025 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 8820 | $45.59 | 22,310.0000 | 79,247,976 | 28.33% | 0.01% |
| Dec. 5, 2025 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 14375 | $45.03 | 31,130.0000 | 79,247,976 | 31.59% | 0.02% |
| Dec. 8, 2025 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 2010 | $46.32 | 20,300.0000 | 79,247,976 | 9.01% | 0.00% |
| Nov. 28, 2025 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 97 | $45.01 | 45,505.0000 | 79,247,976 | 0.21% | 0.00% |
| Oct. 15, 2025 | Kelly Thomas Patrick | Chief Financial Officer | A | Restricted Share Units | 30000 | $0.00 | 30,000.0000 | 79,247,976 | 9999.99% | 0.04% |
| Oct. 15, 2025 | Kelly Thomas Patrick | Chief Financial Officer | A | Share Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 79,247,976 | 9999.99% | 0.28% |
| Oct. 1, 2025 | MORTIMER IAN | PRESIDENT, CEO & INTERIM CFO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 79,247,976 | 100.00% | 0.03% |
| Oct. 1, 2025 | MORTIMER IAN | PRESIDENT, CEO & INTERIM CFO | M | Common Shares | 25000 | $7.69 | 70,602.0000 | 79,247,976 | 54.82% | 0.03% |
| Oct. 1, 2025 | MORTIMER IAN | PRESIDENT, CEO & INTERIM CFO | S | Common Shares | 25000 | $40.16 | 45,602.0000 | 79,247,976 | 35.41% | 0.03% |
| June 23, 2025 | Cline Darren S | Chief Commercial Officer | A | Share Option (Right to Buy) | 185800 | $0.00 | 185,800.0000 | 77,894,643 | 9999.99% | 0.24% |
| June 5, 2025 | Machado Patrick | Not found | A | Share Option (Right to Buy) | 17012 | $0.00 | 17,012.0000 | 77,894,643 | 9999.99% | 0.02% |
| June 5, 2025 | PATOU GARY | Not found | A | Restricted Share Units | 2645 | $0.00 | 2,645.0000 | 77,894,643 | 9999.99% | 0.00% |
| June 5, 2025 | PATOU GARY | Not found | A | Share Option (Right to Buy) | 17012 | $0.00 | 17,012.0000 | 77,894,643 | 9999.99% | 0.02% |
| June 5, 2025 | GANNON STEVEN | Not found | A | Share Option (Right to Buy) | 17012 | $0.00 | 17,012.0000 | 77,894,643 | 9999.99% | 0.02% |
| June 5, 2025 | Svoronos Dawn | Not found | A | Share Option (Right to Buy) | 17012 | $0.00 | 17,012.0000 | 77,894,643 | 9999.99% | 0.02% |
| June 5, 2025 | Svoronos Dawn | Not found | A | Restricted Share Units | 2645 | $0.00 | 2,645.0000 | 77,894,643 | 9999.99% | 0.00% |
| June 5, 2025 | Cannon Gillian | Not found | A | Restricted Share Units | 2645 | $0.00 | 2,645.0000 | 77,894,643 | 9999.99% | 0.00% |
| June 5, 2025 | Cannon Gillian | Not found | A | Share Option (Right to Buy) | 17012 | $0.00 | 17,012.0000 | 77,894,643 | 9999.99% | 0.02% |
| June 5, 2025 | GANNON STEVEN | Not found | A | Restricted Share Units | 2645 | $0.00 | 2,645.0000 | 77,894,643 | 9999.99% | 0.00% |
| June 5, 2025 | GANNON STEVEN | Not found | S | Common Shares | 3 | $30.48 | 7,141.0000 | 77,894,643 | 0.04% | 0.00% |
| June 5, 2025 | GAROFALO ELIZABETH A. | Not found | A | Restricted Share Units | 2645 | $0.00 | 2,645.0000 | 77,894,643 | 9999.99% | 0.00% |
| June 5, 2025 | GAROFALO ELIZABETH A. | Not found | A | Share Option (Right to Buy) | 17012 | $0.00 | 17,012.0000 | 77,894,643 | 9999.99% | 0.02% |
| June 5, 2025 | Gover Justin D. | Not found | A | Restricted Share Units | 2645 | $0.00 | 2,645.0000 | 77,894,643 | 9999.99% | 0.00% |
| June 5, 2025 | Gover Justin D. | Not found | A | Share Option (Right to Buy) | 17012 | $0.00 | 17,012.0000 | 77,894,643 | 9999.99% | 0.02% |
| June 5, 2025 | Machado Patrick | Not found | A | Restricted Share Units | 2645 | $0.00 | 2,645.0000 | 77,894,643 | 9999.99% | 0.00% |
| May 14, 2025 | GANNON STEVEN | Not found | M | Stock Option (Right to Buy) | 5144 | $0.00 | 0.0000 | 77,894,643 | 100.00% | 0.01% |
| May 14, 2025 | GANNON STEVEN | Not found | M | Common Shares | 5144 | $12.57 | 7,144.0000 | 77,894,643 | 257.20% | 0.01% |
| March 12, 2025 | DiFabio Andrea | Chief Legal Officer | A | Share Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 77,894,643 | 9999.99% | 0.10% |
| March 12, 2025 | DiFabio Andrea | Chief Legal Officer | A | Restricted Share Units | 15000 | $0.00 | 15,000.0000 | 77,894,643 | 9999.99% | 0.02% |
| March 12, 2025 | MORTIMER IAN | PRESIDENT & CEO | A | Share Option (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 77,894,643 | 9999.99% | 0.35% |
| March 12, 2025 | MORTIMER IAN | PRESIDENT & CEO | A | Restricted Share Units | 50000 | $0.00 | 50,000.0000 | 77,894,643 | 9999.99% | 0.06% |
| March 12, 2025 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | A | Share Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 77,894,643 | 9999.99% | 0.10% |
| March 12, 2025 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | A | Restricted Share Units | 15000 | $0.00 | 15,000.0000 | 77,894,643 | 9999.99% | 0.02% |
| Jan. 27, 2025 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 15166 | $40.46 | 45,602.0000 | 77,894,643 | 24.96% | 0.02% |
| Jan. 27, 2025 | MORTIMER IAN | PRESIDENT & CEO | M | Common Shares | 1149 | $17.76 | 46,751.0000 | 77,894,643 | 2.52% | 0.00% |
| Jan. 27, 2025 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 1149 | $41.07 | 45,602.0000 | 77,894,643 | 2.46% | 0.00% |
| Jan. 23, 2025 | MORTIMER IAN | PRESIDENT & CEO | M | Stock Option (Right to Buy) | 16217 | $0.00 | 38,783.0000 | 77,894,643 | 29.49% | 0.02% |
| Jan. 27, 2025 | MORTIMER IAN | PRESIDENT & CEO | M | Stock Option (Right to Buy) | 16315 | $0.00 | 0.0000 | 77,894,643 | 100.00% | 0.02% |
| Jan. 24, 2025 | MORTIMER IAN | PRESIDENT & CEO | M | Stock Option (Right to Buy) | 22468 | $0.00 | 16,315.0000 | 77,894,643 | 57.93% | 0.03% |
| Jan. 23, 2025 | MORTIMER IAN | PRESIDENT & CEO | M | Common Shares | 16217 | $17.76 | 61,819.0000 | 77,894,643 | 35.56% | 0.02% |
| Jan. 23, 2025 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 16217 | $40.08 | 45,602.0000 | 77,894,643 | 26.23% | 0.02% |
| Jan. 24, 2025 | MORTIMER IAN | PRESIDENT & CEO | M | Common Shares | 22468 | $17.76 | 68,070.0000 | 77,894,643 | 49.27% | 0.03% |
| Jan. 24, 2025 | MORTIMER IAN | PRESIDENT & CEO | S | Common Shares | 22468 | $40.20 | 45,602.0000 | 77,894,643 | 33.01% | 0.03% |
| Jan. 27, 2025 | MORTIMER IAN | PRESIDENT & CEO | M | Common Shares | 15166 | $17.76 | 60,768.0000 | 77,894,643 | 33.26% | 0.02% |
| Dec. 18, 2024 | AULIN SHERRY | Chief Financial Officer | M | Stock Option (Right to Buy) | 9334 | $0.00 | 0.0000 | 77,926,205 | 100.00% | 0.01% |
| Dec. 18, 2024 | AULIN SHERRY | Chief Financial Officer | M | Common Shares | 9334 | $9.44 | 9,334.0000 | 77,926,205 | 9999.99% | 0.01% |
| Dec. 18, 2024 | AULIN SHERRY | Chief Financial Officer | F | Common Shares | 2135 | $41.28 | 7,199.0000 | 77,926,205 | 22.87% | 0.00% |
| Dec. 18, 2024 | AULIN SHERRY | Chief Financial Officer | S | Common Shares | 7199 | $41.23 | 0.0000 | 77,926,205 | 100.00% | 0.01% |
| Dec. 18, 2024 | AULIN SHERRY | Chief Financial Officer | M | Common Shares | 16000 | $11.58 | 16,000.0000 | 77,926,205 | 9999.99% | 0.02% |
| Dec. 18, 2024 | AULIN SHERRY | Chief Financial Officer | F | Common Shares | 4490 | $41.28 | 11,510.0000 | 77,926,205 | 28.06% | 0.01% |
| Dec. 18, 2024 | AULIN SHERRY | Chief Financial Officer | S | Common Shares | 11510 | $41.19 | 0.0000 | 77,926,205 | 100.00% | 0.01% |
| Dec. 18, 2024 | AULIN SHERRY | Chief Financial Officer | M | Stock Option (Right to Buy) | 16000 | $0.00 | 6,000.0000 | 77,926,205 | 72.73% | 0.02% |
| Nov. 22, 2024 | PATOU GARY | Not found | M | Stock Option (Right to Buy) | 3500 | $0.00 | 0.0000 | 77,926,205 | 100.00% | 0.00% |
| Nov. 22, 2024 | PATOU GARY | Not found | M | Stock Option (Right to Buy) | 3086 | $0.00 | 0.0000 | 77,926,205 | 100.00% | 0.00% |
| Nov. 22, 2024 | PATOU GARY | Not found | S | Common Shares | 2040 | $41.05 | 28,475.0000 | 77,926,205 | 6.69% | 0.00% |
| Nov. 22, 2024 | PATOU GARY | Not found | F | Common Shares | 1046 | $39.80 | 30,515.0000 | 77,926,205 | 3.31% | 0.00% |
| Nov. 22, 2024 | PATOU GARY | Not found | M | Common Shares | 3086 | $13.48 | 31,561.0000 | 77,926,205 | 10.84% | 0.00% |
| Nov. 22, 2024 | PATOU GARY | Not found | S | Common Shares | 2851 | $41.11 | 28,475.0000 | 77,926,205 | 9.10% | 0.00% |
| Nov. 22, 2024 | PATOU GARY | Not found | F | Common Shares | 649 | $39.80 | 31,326.0000 | 77,926,205 | 2.03% | 0.00% |
| Nov. 22, 2024 | PATOU GARY | Not found | M | Common Shares | 3500 | $7.38 | 31,975.0000 | 77,926,205 | 12.29% | 0.00% |
| June 5, 2024 | GAROFALO ELIZABETH A. | Not found | A | Stock Option (Right to Buy) | 15542 | $0.00 | 15,542.0000 | 66,889,005 | 9999.99% | 0.02% |
| June 5, 2024 | Gover Justin D. | Not found | A | Stock Option (Right to Buy) | 15542 | $0.00 | 15,542.0000 | 66,889,005 | 9999.99% | 0.02% |
| June 5, 2024 | Machado Patrick | Not found | A | Stock Option (Right to Buy) | 15542 | $0.00 | 15,542.0000 | 66,889,005 | 9999.99% | 0.02% |
| June 5, 2024 | Svoronos Dawn | Not found | A | Stock Option (Right to Buy) | 15542 | $0.00 | 15,542.0000 | 66,889,005 | 9999.99% | 0.02% |
| June 5, 2024 | PATOU GARY | Not found | A | Stock Option (Right to Buy) | 15542 | $0.00 | 15,542.0000 | 66,889,005 | 9999.99% | 0.02% |
| June 5, 2024 | Cannon Gillian | Not found | A | Stock Option (Right to Buy) | 15542 | $0.00 | 15,542.0000 | 66,889,005 | 9999.99% | 0.02% |
| June 5, 2024 | GANNON STEVEN | Not found | A | Stock Option (Right to Buy) | 15542 | $0.00 | 15,542.0000 | 66,889,005 | 9999.99% | 0.02% |
| March 11, 2024 | DiFabio Andrea | Chief Legal Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 66,889,005 | 9999.99% | 0.15% |
| March 11, 2024 | Von Seggern Christopher | Chief Commercial Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 66,889,005 | 9999.99% | 0.15% |
| March 11, 2024 | AULIN SHERRY | Chief Financial Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 66,889,005 | 9999.99% | 0.15% |
| March 11, 2024 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 66,889,005 | 9999.99% | 0.15% |
| March 11, 2024 | EMPFIELD JAMES R. | EVP, Drug Discovery | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 66,889,005 | 9999.99% | 0.10% |
| March 11, 2024 | ROBIN SHERRINGTON | EVP, Strategy & Innovation | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 66,889,005 | 9999.99% | 0.10% |
| March 11, 2024 | MORTIMER IAN | PRESIDENT & CEO | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 66,889,005 | 9999.99% | 0.37% |
| March 8, 2024 | GAROFALO ELIZABETH A. | Not found | S | Common Shares | 2092 | $45.69 | 0.0000 | 66,889,005 | 100.00% | 0.00% |
| March 8, 2024 | GAROFALO ELIZABETH A. | Not found | M | Common Shares | 3500 | $18.56 | 3,500.0000 | 66,889,005 | 9999.99% | 0.01% |
| March 8, 2024 | GAROFALO ELIZABETH A. | Not found | F | Common Shares | 1408 | $46.16 | 2,092.0000 | 66,889,005 | 40.23% | 0.00% |
| March 8, 2024 | GAROFALO ELIZABETH A. | Not found | M | Stock Option (Right to Buy) | 3500 | $0.00 | 16,500.0000 | 66,889,005 | 17.50% | 0.01% |
| March 7, 2024 | GANNON STEVEN | Not found | S | Common Shares | 1000 | $46.45 | 14,000.0000 | 66,889,005 | 6.67% | 0.00% |
| March 7, 2024 | ROBIN SHERRINGTON | EVP, Strategy & Innovation | M | Stock Option (Right to Buy) | 7407 | $0.00 | 0.0000 | 66,889,005 | 100.00% | 0.01% |
| March 7, 2024 | GANNON STEVEN | Not found | S | Common Shares | 2000 | $46.20 | 2,000.0000 | 66,889,005 | 50.00% | 0.00% |
| March 7, 2024 | GANNON STEVEN | Not found | S | Common Shares | 5000 | $46.30 | 4,000.0000 | 66,889,005 | 55.56% | 0.01% |
| March 7, 2024 | GANNON STEVEN | Not found | S | Common Shares | 5000 | $46.25 | 9,000.0000 | 66,889,005 | 35.71% | 0.01% |
| March 7, 2024 | ROBIN SHERRINGTON | EVP, Strategy & Innovation | M | Common Shares | 1234 | $9.85 | 9,632.0000 | 66,889,005 | 14.69% | 0.00% |
| March 7, 2024 | ROBIN SHERRINGTON | EVP, Strategy & Innovation | F | Common Shares | 215 | $45.96 | 9,417.0000 | 66,889,005 | 2.23% | 0.00% |
| March 7, 2024 | ROBIN SHERRINGTON | EVP, Strategy & Innovation | M | Common Shares | 7407 | $9.85 | 16,824.0000 | 66,889,005 | 78.66% | 0.01% |
| March 7, 2024 | ROBIN SHERRINGTON | EVP, Strategy & Innovation | F | Common Shares | 1289 | $45.96 | 15,535.0000 | 66,889,005 | 7.66% | 0.00% |
| March 7, 2024 | ROBIN SHERRINGTON | EVP, Strategy & Innovation | S | Common Shares | 1019 | $46.15 | 14,516.0000 | 66,889,005 | 6.56% | 0.00% |
| March 7, 2024 | ROBIN SHERRINGTON | EVP, Strategy & Innovation | M | Stock Option (Right to Buy) | 1234 | $0.00 | 0.0000 | 66,889,005 | 100.00% | 0.00% |
| March 7, 2024 | ROBIN SHERRINGTON | EVP, Strategy & Innovation | S | Common Shares | 6118 | $46.30 | 8,398.0000 | 66,889,005 | 42.15% | 0.01% |
| Dec. 29, 2023 | ROBIN SHERRINGTON | EVP, Strategy & Innovation | J | Common Shares | 8398 | $0.00 | 8,398.0000 | 60,542,142 | 50.00% | 0.01% |